期刊文献+

聚山梨醇酯80修饰H102聚乳酸-羟基乙酸纳米粒的脑靶向性研究及细胞毒性评价 被引量:1

Brain targeting property and cytotoxicity evaluation of H102 loaded PEG-PLGA nanoparticles coated with polysorbate 80
下载PDF
导出
摘要 目的:考察聚山梨醇酯80修饰H102聚乳酸-羟基乙酸纳米粒(PS-H102-NP)的脑靶向性,并对其细胞毒性进行评价。方法:将H102-NP和PS-H102-NP两种制剂经小鼠静脉注射给药,采用LC-MS液质联用分析法测定给药后5、15、30、45、60和120 min时的血浆及脑组织中的药物浓度。采用MTT法评价聚山梨醇酯80和纳米粒对BCECs细胞的毒性。结果:PS-H102-NP在脑内的半衰期和滞留时间延长,清除率下降,其AUC值是H102-NP的1.42倍。2%以下浓度的聚山梨醇酯80具有较佳的安全性,PS-H102-NP的毒性较H102-NP小。结论:PS-H102-NP具有较好的脑靶向性和低毒性,为其应用于阿尔茨海默病的治疗提供实验依据。 Objective: To study the brain targeting property of H102 loaded PEG-PLGA nanoparticles coated with polysorhate 80 (PS- H 102-NP) and evaluate its cytotoxicity. Methods: After intravenous injection of H 102-NP and PS-H102-NP in mice, plasma and brain tissue were collected at 5, 15, 30, 45, 60 and 120 min and drug concentration were determined by LC-MS. MTY assay was used to evalu- ate the cytotoxieity of polysorbate 80 and PS-H102-NP on BCECs. Results: PS-H102-NP showed long half life and mean residence time with a low clearance. The AUC of PS-H102-NP was 1.42 times higher than that of H102-NP. Polysorbate 80 below 2% showed good safety on BCECs and the toxicity of PS-HI02-NP was lower than that of H102-NP. Conclusion: PS-H102-NP show good brain targeting property and low cytotoxicity, providing experimental data to its application for the treatment of Alzheimer' s disease.
出处 《天津医科大学学报》 2013年第2期93-96,共4页 Journal of Tianjin Medical University
基金 "国家重大新药创制科技"重大专项(2009ZX09103-029)
关键词 聚山梨醇酯80 H102 聚乳酸-羟基乙酸纳米粒 脑靶向性 细胞毒性 polysorbate 80 H102 PEG-PLGA brain targeting property cytotoxicity
  • 相关文献

参考文献6

二级参考文献27

  • 1秦川,朱华,张兵林,常洋,尹红星,刘亚莉.阿尔茨海默症转基因动物模型脑组织病理学及免疫组化研究[J].中国实验动物学报,2000,8(4):213-217. 被引量:21
  • 2[1]Bickel U,Yoshikawa T,Pardridge W.Delivery of peptides and proteins through the blood-brain barrier.Adv Drug Deliv Rev,2001,46(1-3):247-279
  • 3[2]Gloor SM,Wachtel M,Bolliger MF et al.Molecular and cellular permeability control at the blood-brain barrier.Brain Res Brain Res Rev,2001,36(2-3):258-264
  • 4[3]Kreuter J.Nanoparticulate systems for brain delivery of drugs.Adv Drug Deliv Rev,2001,47(1):65-81
  • 5[4]Kreuter J,Alyautdin RN,Kharkevich DA et al.Passage of peptides through the blood-brain barrier with colloidal polymer particles(nanoparticles).Brain Res,1995,674(1):171-174
  • 6[5]Gulyaev AE,Gelperina SE,Skidan IN et al.Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.Pharm Res,1999,16(10):1564-1569
  • 7[6]Lockman PR,Mumper R J,Khan MA et al.Nanoparticle technology for drug delivery across the blood-brain barrier.Drug Dev Ind Pharm,2002,28(1):1-13
  • 8[7]Koziara JM,Lockman PR,Allen DD et al.In situ blood-brain barrier transport of annoparticles.Pharm Res,2003,20(11):1772-1778
  • 9[8]Sun W,Wang H,Hu Y et al.Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain.Biomaterials,2004,25(15):3065-3071
  • 10[9]Fessi C,Devissaguet J,Puisieux F et al.Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles.U.S.Patent 5,118,528

共引文献17

同被引文献25

  • 1王华芳,胡豫,孙望强,谢长生,魏文宁,周薇,方峻.聚乳酸纳米微粒的制备及其在鼠脑组织中的选择性分布研究[J].中国生物医学工程学报,2004,23(4):311-315. 被引量:4
  • 2李范珠,程巧鸳.神经毒素PLGA纳米粒的制备及鼻黏膜给药的药动学研究[J].浙江中医药大学学报,2006,30(2):211-213. 被引量:2
  • 3刘建军,张洪,黄海燕,潘一峰,袁建辉.表阿霉素α-聚氰基丙烯酸正丁酯纳米粒生物安全性的初步评价[J].中国现代医学杂志,2007,17(20):2453-2455. 被引量:4
  • 4Xia H,Gao X,Gu G,et al.Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery[J] .Int J Pharm,2012,436:840-850.
  • 5Zhang X,Liu L,Chai G,et al.Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats[J] .Drug Dev Ind Pharm,2013,39(11):1618-1624.
  • 6Chen C,Mei H,Shi W,et al.EGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interference[J] .Plos One,2013,8(4):e60860.
  • 7Yan L,Wang H,Jiang Y,et al.Cell-penetrating peptide-modified PLGA nanoparticles for enhanced nose-to-brain macromolecular delivery[J] .Macromolecular Research,2013,21(4):435-441.
  • 8Liu Z,Jiang M,Kang T,et al.Lactoferrin-modified PEG-coPCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration[J] .Biomaterials,2013,34(15):3870-3881.
  • 9Ebrahimi Shahmabadi H,Movahedi F,Koohi Mofta khari Esfahani M,et al.Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma[J] .Tumor Biol,2014,35(5):4799-4806.
  • 10Lin Y,Pan Y,Shi Y,et al.Delivery of large molecules viapoly(butyl cyanoacrylate)nanoparticles into the injured rat brain[J] .Nanotechnology,2012,23:165101.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部